Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H.

Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H.

A genetically reshaped human IgG1 monoclonal antibody (CAMPATH-1H) was used to treat two patients with non-Hodgkin lymphoma. Doses of 1-20 mg daily were given intravenously for up to 43 days. In both patients lymphoma cells were cleared from the blood and bone marrow and splenomegaly resolved. One p...

書目詳細資料
Main Authors:	Hale, G, Dyer, M, Clark, MR, Phillips, J, Marcus, R, Riechmann, L, Winter, G, Waldmann, H
格式:	Journal article
語言:	English
出版:	1988

相似書籍

REMISSION INDUCTION IN PATIENTS WITH LYMPHOID MALIGNANCIES USING UNCONJUGATED CAMPATH-1 MONOCLONAL-ANTIBODIES
由: Dyer, M, et al.
出版: (1990)

Specificity of monoclonal antibody Campath-1.
由: Hale, G, et al.
出版: (1988)

CAMPATH-1 monoclonal antibodies in bone marrow transplantation.
由: Hale, G, et al.
出版: (1994)

EFFECTS OF MONOCLONAL-ANTIBODIES OF THE CAMPATH SERIES INVIVO - REQUIREMENTS FOR EFFECTIVE ANTIBODY THERAPY
由: Dyer, M, et al.
出版: (1988)

Rat monoclonal antibodies for bone marrow transplantation--the CAMPATH series.
由: Waldmann, H, et al.
出版: (1985)

CAMPATH-1 monoclonal antibody therapy in severe refractory autoimmune thrombocytopenic purpura.
由: Lim, S, et al.
出版: (1993)

RAT MONOCLONAL-ANTIBODIES FOR BONE-MARROW TRANSPLANTATION (BMT) - THE CAMPATH SERIES
由: Waldmann, H, et al.
出版: (1985)

Sustained remission of severe resistant autoimmune neutropenia with Campath-1H.
由: Killick, S, et al.
出版: (1997)

Reshaping human antibodies for therapy.
由: Riechmann, L, et al.
出版: (1988)

The CAMPATH-1 antigen (CDw52).
由: Hale, G, et al.
出版: (1990)

Monoclonal antibody therapy of diffuse cutaneous scleroderma with CAMPATH-1H.
由: Isaacs, J, et al.
出版: (1996)

CAMPATH: from concept to clinic.
由: Waldmann, H, et al.
出版: (2005)

Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies.
由: Naparstek, E, et al.
出版: (1999)

Reversal of allograft rejection using the monoclonal antibody, Campath-1G.
由: Friend, P, et al.
出版: (1991)

Impact on T-cell depletion and CD34+ cell recovery using humanised CD52 monoclonal antibody (CAMPATH-1H) in BM and PSBC collections; comparison with CAMPATH-1M and CAMPATH-1G.
由: Williams, R, et al.
出版: (2000)

Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1H.
由: Isaacs, J, et al.
出版: (1995)

ISOTYPE VARIANTS OF CAMPATH-1 ANTIBODY - REQUIREMENTS FOR EFFECTIVE ANTIBODY ACTION INVIVO
由: Dyer, M, et al.
出版: (1989)

Anti-globulin responses to rat and humanized CAMPATH-1 monoclonal antibody used to treat transplant rejection.
由: Rebello, P, et al.
出版: (1999)

Pilot study of CAMPATH-1, a rat monoclonal antibody that fixes human complement, as an immunosuppressant in organ transplantation.
由: Hale, G, et al.
出版: (1986)

Effects of CAMPATH-1 antibodies in vivo in patients with lymphoid malignancies: influence of antibody isotype.
由: Dyer, M, et al.
出版: (1989)

Availability of Campath-1 antibodies for bone marrow transplantation.
由: Hale, G, et al.
出版: (1995)

Prevention of immune-mediated corneal graft destruction with the anti-lymphocyte monoclonal antibody, CAMPATH-1H.
由: Newman, D, et al.
出版: (1995)

CAMPATH-1 MOAB IN THE TREATMENT OF REFRACTORY AUTOIMMUNE THROMBOCYTOPENIC PURPURA (ATP)
由: Lim, S, et al.
出版: (1993)

Reactivity of rat monoclonal antibody CAMPATH-1 with human leukaemia cells and its possible application for autologous bone marrow transplantation.
由: Hale, G, et al.
出版: (1985)

CAMPATH-1H in inflammatory arthritis.
由: Watts, R, et al.
出版: (1993)

T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation.
由: Hale, G, et al.
出版: (1988)

Recent results using CAMPATH-1 antibodies to control GVHD and graft rejection.
由: Hale, G, et al.
出版: (1996)

In vivo 'purging' of residual disease in CLL with Campath-1H.
由: Dyer, M, et al.
出版: (1997)

Leukaemic relapse after Campath 1-treated bone-marrow transplantation for leukaemia.
由: Waldmann, H, et al.
出版: (1987)

ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA USING CAMPATH-1 MONOCLONAL-ANTIBODIES AND POSTTRANSPLANT ALLOIMMUNIZATION WITH DONOR LYMPHOCYTES
由: Naparstek, E, et al.
出版: (1993)

CAMPATH-IH in multiple sclerosis.
由: Moreau, T, et al.
出版: (1996)

Campath-1 Abs 'in the bag' for hematological malignancies: the Cape Town experience.
由: Novitzky, N, et al.
出版: (2004)

Efficient complement-mediated lysis of cells containing the CAMPATH-1 (CDw52) antigen.
由: Xia, M, et al.
出版: (1993)

Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy.
由: Lockwood, C, et al.
出版: (1993)

Evaluation of non-myeloablative conditioning combining beam with in vivo pre-transplant Campath-IG for allogeneic transplantation in patients with lymphoma.
由: Russell, N, et al.
出版: (1999)

CAMPATH-1 antibodies in stem-cell transplantation.
由: Hale, G, et al.
出版: (2001)

Appropriate targets for monoclonal antibodies in the induction of transplantation tolerance.
由: Waldmann, H, et al.
出版: (2001)

TREATMENT OF RHEUMATOID-ARTHRITIS WITH HUMANIZED ANTILYMPHOCYTE ANTIBODY CAMPATH-1H
由: Watts, R, et al.
出版: (1992)

Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nonmyeloablative conditioning?
由: Hale, G, et al.
出版: (2002)

Risks of developing Epstein-Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants. CAMPATH Users.
由: Hale, G, et al.
出版: (1998)